- Home
- NTRB vs MDAI Comparison
NTRB vs MDAI Comparison
Compare NTRB & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- MDAI
- Stock Information
- Founded
- NTRB 2016
- MDAI 2013
- Country
- NTRB United States
- MDAI United States
- Employees
- NTRB N/A
- MDAI N/A
- Industry
- NTRB Industrial Specialties
- MDAI Medical/Dental Instruments
- Sector
- NTRB Health Care
- MDAI Health Care
- Exchange
- NTRB Nasdaq
- MDAI Nasdaq
- Market Cap
- NTRB 59.1M
- MDAI 51.5M
- IPO Year
- NTRB N/A
- MDAI N/A
- Fundamental
- Price
- NTRB $7.50
- MDAI $2.12
- Analyst Decision
- NTRB Buy
- MDAI Strong Buy
- Analyst Count
- NTRB 1
- MDAI 2
- Target Price
- NTRB $13.00
- MDAI $4.75
- AVG Volume (30 Days)
- NTRB 82.0K
- MDAI 455.5K
- Earning Date
- NTRB 05-30-2025
- MDAI 08-11-2025
- Dividend Yield
- NTRB N/A
- MDAI N/A
- EPS Growth
- NTRB N/A
- MDAI N/A
- EPS
- NTRB N/A
- MDAI N/A
- Revenue
- NTRB $2,398,437.00
- MDAI $29,962,000.00
- Revenue This Year
- NTRB $560.75
- MDAI N/A
- Revenue Next Year
- NTRB $588.39
- MDAI $56.05
- P/E Ratio
- NTRB N/A
- MDAI N/A
- Revenue Growth
- NTRB 18.92
- MDAI 55.21
- 52 Week Low
- NTRB $3.72
- MDAI $0.82
- 52 Week High
- NTRB $11.78
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- NTRB 59.79
- MDAI 67.16
- Support Level
- NTRB $7.00
- MDAI $1.97
- Resistance Level
- NTRB $7.90
- MDAI $2.28
- Average True Range (ATR)
- NTRB 0.66
- MDAI 0.16
- MACD
- NTRB -0.01
- MDAI 0.01
- Stochastic Oscillator
- NTRB 37.45
- MDAI 82.81
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.